CHERYL MILLER: Open Payments
NPI 1023748639 · BROADWAY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 64 payments from 13 companies in 2025. Trend: 2023 $689 · 2024 $782 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $253 |
| Collegium Pharmaceutical, Inc. | 14 | $242 |
| PFIZER INC. | 14 | $195 |
| Boston Scientific Corporation | 3 | $185 |
| Tonix Medicines, Inc. | 3 | $120 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $62 |
| Lundbeck LLC | 2 | $47 |
| Lilly USA, LLC | 2 | $31 |
| Ardelyx, Inc. | 2 | $30 |
Products named: NURTEC ODT, Intracept, Belbuca, QULIPTA, JOURNAVX, UBRELVY, XTAMPZA, RELISTOR.
Industry payments across VA — which companies pay providers there.
